ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
FDA workshop: Insights on inhaled antifungals and antibacterials
Developing antibiotics for children: There are no easy answers
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
Melinta goes bankrupt / Never let a good crisis go to waste
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
What does an antibiotic cost to develop? What is it worth? How to afford it?
Public meeting on the LPAD Pathway: Post-meeting thoughts (wonkish)
Two new oral drugs for gonorrhea!
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
NIAID workshop: What is a robust PK-PD package?
The 37,000-year view: Infections in Eurasia
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet